A phase I clinical trial of an oral formulation of the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) Meeting Abstract
| Authors: | Kelly, W.; O'connor, O.; Richon, V. M.; Tong, W.; Rao, T. D.; Chiao, J.; O'Brien, J. P.; Rifkind, R. A.; Marks, P. A.; Scher, H. I. |
| Abstract Title: | A phase I clinical trial of an oral formulation of the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) |
| Meeting Title: | 14th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics |
| Journal Title: | European Journal of Cancer |
| Volume: | 38 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2002 Nov 19-22 |
| Meeting Location: | Frankfurt, Germany |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2002-11-01 |
| Start Page: | S88 |
| Language: | English |
| ACCESSION: | WOS:000179895700288 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0959-8049(02)80937-6 |
| PUBMED: | 12526123 |
| Notes: | Meeting Abstract: 286 -- 14th EORTC/NCI/AACR Symposium on Molecular Targets and Cancer Therapeutics -- NOV 19-22, 2002 -- FRANKFURT, GERMANY -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
